Berita

The State of AI in Drug Discovery

GEN’s virtual summit returns on November 4 to examine how AI is reshaping R&D ti...

Epigenetics Underlies Comparatively Accelerated Molecul...

Large dogs tend to be shorter lived than their smaller counterparts, and a new s...

ARPA-H’s BoSS Program Funds Three Teams Tackling Cold C...

Cell therapies and other biologics depend on ultracold storage and tightly contr...

Gut Microbes Trigger Calprotectin to Protect Newborns f...

Newborn gut microbes activate epithelial calprotectin production, strengthening ...

Secrets of Oldest Land Animal’s 194-Year Lifespan Revea...

Researchers studying a giant tortoise named Jonathan—who is the oldest known liv...

Adding Low-Fidelity Data to ML Training Sets Could Yiel...

Low-fidelity trend information should be incorporated into the data sets used to...

Big Data Opportunities in Biomanufacturing

Industry-wide standardization and collaboration leverage big data in ways that h...

Hybrid Digital Twins Developed for Future Autonomous Labs

An academic laboratory is developing a hybrid digital twin that integrates a mec...

Electrical Signals Sharpen Bioprocess Control

Electrical signatures could give bioprocess engineers an earlier view of cell he...

Kagan, Soai Win 2026 Nobel Prize in Chemistry for Disco...

Henri Kagan, PhD, and Kenso Soai, PhD, shared this year's award for the discover...

$2-million investment accelerates psychedelic medicine ...

St. Joseph’s Healthcare Hamilton is expanding research into the potential medica...

Wearable ‘Skincubator’ could transform skin-to-skin car...

A new wearable device being studied in neonatal intensive care units could make ...

Screening physicians for cognitive impairment remains r...

While nearly one-quarter of U.S. physicians are 65 or older, a new study found t...

Expanding the Possibilities of Next-Generation Sequencing

Sequencing by expansion (SBX) and Roche’s AXELIOS 1 platform introduce a new app...

Biologics Standards for Innovation, Quality and Access

This GEN Spotlight on Biologics Standards for Innovation, Quality and Access bri...

Shionogi Grows Rare Disease Portfolio with $2B IntraBio...

Shionogi signaled its intent to focus on rare disease drugs in April when it acq...